Highlights for scientists and researchers

Scientific and clinical research is vital to the development of new methods and technologies for the diagnosis, treatment and prevention of respiratory diseases.

Scientists and researchers progress our understanding of various mechanisms involved in lung biology, including lung development and lung pathophysiology, the cell and molecular biology of the respiratory tract in health, disease and development, and the basis of injury to the lungs and new approaches to treatment for lung injury.


Hear from the Basic and Translational Sciences Assembly    

Catherine Greene is Head of the ERS Basic and Translational Sciences Assembly.

She is Associate Professor in the Department of Clinical Microbiology at the Royal College of Surgeons in Ireland (RCSI) and is a member of the editorial boards of Scientific Reports, Journal of Innate Immunity and European Respiratory Review.

She has served on scientific review panels for the European Commission, US Alpha-1 Foundation, Austrian Science Fund, Belgian Research Foundation and national funding bodies in Ireland.

Q: What makes the ERS Congress unique for scientists and clinical researchers?

A: This year’s virtual ERS Congress is the perfect opportunity for scientists and clinical researchers to hear about the latest developments in the mechanisms underlying respiratory diseases and exciting new advances related to emerging therapies. Uniquely, the first day is largely devoted to groundbreaking research and cutting-edge developments in COVID-19 basic, translational and clinical research. 

Q: What can scientists and clinical researchers expect to gain from taking part in this year's Congress?

A: This will be the only event in 2020 where all the latest information on basic and translational lung science is presented. Carefully planned themed sessions on topics selected by the membership will be presented by leaders in the field across four days. The poster and oral sessions will present the newest findings across basic and translational lung science grouped by theme whilst the symposia, Hot Topics, Expert View and Year-in-Review sessions are ideal for updating and refreshing specialist and general knowledge.

Q: In your opinion, what will be the popular topics for scientists and clinical researchers at this year's Congress, and what will be a particular highlight for you?

A: The 'Scientific year in review' (pre-Congress content available from Monday 24 August) is always a popular event for Assembly 3 members and this year will focus on the mechanisms underlying lung disease across the lifetime. Other highlights include the Hot Topic '(Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration' (Tuesday 8 September, 14:3015:30 CEST) and the symposia 'The ageing lung epithelium: effects on repair and regeneration' (Tuesday 8 September, 16:5017:50 CEST) and 'Human ex vivo models of interstitial lung disease' (Tuesday 8 September, 18:0019:00 CEST). I am looking forward to the oral and poster presentations, especially by early career members, where the most exciting new developments in lung biology data will be presented. I would also encourage scientists and clinical researchers to check out the Expert Views 'Genom revolution: Human Lung Cell Atlas', 'CRISPR for dummies', and 'Replacement of animal models in respiratory medicine' (pre-Congress content available from Monday 24 August).

Recommended sessions for scientists and clinical researchers

This year’s virtual Congress has a strong scientific and clinical research led programme, featuring a variety of activities that will deliver the latest updates in respiratory medicine.

Our top picks include:

Learn more about the Basic and Translational Sciences Assembly

View all programme highlights


Copyright © 2020 - ERS International Congress - European Respiratory Society. All Rights Reserved.